Dow 30 Stock Roundup: Pfizer Drug Trial Dents, P&G Ups Dividend – Analyst Blog

By | April 11, 2014

Scalper1 News

The Dow experienced an extremely volatile week due to the erratic behavior of momentum stocks. An important pharma component dragged down the index on Monday following confusion over trial results. The blue chip index moved up Scalper1 News

Scalper1 News